Trials / Terminated
TerminatedNCT02561247
Prismaflex HF20 Set and Prismaflex® System 7.10/7.20 for Acute Continuous Renal Replacement Therapy (CRRT) in Children
Clinical Evaluation of the Prismaflex HF20 Set and Prismaflex® System 7.10 for Acute CRRT in Children
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Vantive Health LLC · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the efficacy of the Gambro Prismaflex® HF20 Set based on testing the hypothesis that it delivers sufficient renal replacement therapy to effectively treat acute kidney injury (AKI) in pediatric patients by reducing blood urea nitrogen (BUN).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Prismaflex HF20 CRRT Filter | |
| DEVICE | Prismaflex® System 7.10 and 7.20 |
Timeline
- Start date
- 2015-11-10
- Primary completion
- 2018-04-06
- Completion
- 2018-04-06
- First posted
- 2015-09-28
- Last updated
- 2025-07-14
- Results posted
- 2021-06-16
Locations
6 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02561247. Inclusion in this directory is not an endorsement.